Kaloyan Takov: Native Lp(a) Carries a Distinct Triglyceride Signature Linked to Cardiovascular Disease
Kaloyan Takov, Research Associate at Imperial College London, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Atherosclerosis, adding:
“As results emerge from the first Lp(a)-lowering outcome trials, particularly following the news that Lp(a)HORIZON did not meet its primary endpoint, it is more important than ever to look beyond Lp(a) levels alone and understand its composition.
Check out our new study in Atherosclerosis, showing that native Lp(a) carries a distinct triglyceride signature linked to incident cardiovascular disease.
These findings challenge conventional classifications and support combining better particle separation with novel technologies to capture lipoprotein heterogeneity.”
Title: Lipoprotein(a) carries triglyceride species associated with incident cardiovascular disease
Authors: Kaloyan Takov, Sider Penkov, Raimund Pechlaner, Eyad Elbahtety, Li Ern Yap, Lukas Schmidt, Sarah E. Berry, Wendy L. Hall, Bhawana Singh, Johann Willeit, Stefan Kiechl, Sotirios Tsimikas, Stefan R. Bornstein, Maria Fedorova, Manuel Mayr
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 13, 2026, 17:28Jim Hoffman: New Potential Predictive Biomarker for Lupus Nephritis
-
Sep 13, 2026, 17:08W. Alberto Sifuentes Giraldo: Urticarial Vasculitis Clinical Features, Systemic Involvement, and Treatment
-
Sep 13, 2026, 16:58Let’s Debunk Some Myths about Blood in SCD – ASCO
-
Sep 13, 2026, 16:56William Wallace: A Magnesium Ion Decides Whether Your Brain Learns or Not
-
Sep 13, 2026, 16:54Meet NBDF’s 2026 Excellence Fellowship Recipients – National Bleeding Disorders Foundation
-
Sep 13, 2026, 16:51Axay Tomar: How Simulation-Based Education Shapes Safer Transfusion Practices
-
Sep 13, 2026, 16:51Edina Cenko: AZURE-HeFH Highlights the LDL-C Treatment Gap in HeFH
-
Sep 13, 2026, 16:49William Aird: Why Is LDH Elevated In Splenic Infarction?
-
Sep 13, 2026, 16:48David McIntosh: PPTA Calls for Action on the Global Shortage of Plasma-Derived Medicines